Susquehanna International Group, LLP Pro Qr Therapeutics N.V. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 42,223 shares of PRQR stock, worth $112,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,223
Previous 96,118
56.07%
Holding current value
$112,735
Previous $159,000
52.2%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PRQR
# of Institutions
52Shares Held
17.4MCall Options Held
37.7KPut Options Held
21.3K-
Privium Fund Management B.V.5.63MShares$15 Million2.56% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$9.68 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.84MShares$4.9 Million0.14% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$2.72 Million1.76% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$2.42 Million0.42% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $191M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...